"/> Invitrogen™ Peptide synthétique SKA2 humain | B-LABO France

Invitrogen™ Peptide synthétique SKA2 humain

Réf. : BL-RE-176120Réf. fabricant : 15399170 50 μg
137,00 € HT

Synthetic Peptide

Gene ID (Entrez)
348235
Espèces
Human
Méthode de purification
purified
Numéro d’adhésion
Q8WVK7
Nom usuel
Human SKA2
Marque
Invitrogen

SKA2 Synthetic Peptide, PEP-0932, from Invitrogen.

Upon entry into mitosis, the cell’s microtubule (MT) network forms the mitotic spindle, allowing the segregation of paired chromosomes. Proteinaceous structures on centromeric chromatin termed kinetochores (KT) are essential for the proper attachment of the chromosomes to the spindle MTs. A recently discovered spindle and kinetochore complex, comprised of proteins SKA1, SKA2, and SKA3, has been found to be required for stable KT-MT interactions and timely anaphase onset. Depletion of either SKA1 or SKA2 by siRNA results in the loss of both proteins from the KT, but does not impact overall KT structure. Cells depleted of the SKA complex undergo a prolonged checkpoint-dependent delay in a metaphase-like state, indicating the importance of the SKA complex in the maintenance of the metaphase plate and spindle checkpoint silencing. SKA2 has also been shown to interact with glucocorticoid receptors and to be involved in glucocorticoid signaling and cell proliferation.

Caractéristiques techniques

MarqueInvitrogen
Réf. B-LABOBL-RE-176120
Réf. fabricant15399170
Gene ID (Entrez)348235
EspècesHuman
Méthode de purificationpurified
Numéro d’adhésionQ8WVK7
Nom usuelHuman SKA2
Concentration200 μg/mL
Contenu et stockage-20°C
FormatLiquid
FormulePBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
À utiliser avec (application)Blocking Assay, Control
Symbole de gène(s)SKA2
LyophiliséNo
Conservateur0.02% sodium azide
Type de produitPeptide
Quantité50 μg
État réglementaireRUO - research use only
Tampon de stockagePBS
Une question, une configuration particulière ?
Contactez-nous pour un devis.